Skip to main content

Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis



Dementia is generally caused by neurodegenerative diseases affecting the brain, which leads to a progressive neurocognitive decline characterized by inability to perform major higher functioning tasks. Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan is one of the main imaging tests performed for diagnostic purposes. However, with FDG-PET being quite expensive and not widely available, an attempt to find an alternative is set. Arterial-spin-labelling magnetic resonance imaging (ASL-MRI) is an increasingly investigated substitute to FDG-PET for the diagnosis of dementia. Thereby, the main purpose of this systematic review and meta-analysis is to compare the diagnostic ability of FDG-PET and ASL-MRI in detecting dementia.


PRISMA checklist for diagnostic test accuracy was employed in outlining this paper. A literature search was done using several search engines including PubMed, Core, and Cochrane. Two researchers (HH and SH) extracted the essential information from all included articles. Risk of bias was evaluated by the Quality Assessment of Diagnostic Accuracy Studies tool, version 2 (QUADAS-2). A qualitative analysis and summary of studies’ results were provided. In addition, a meta-analysis was executed based on the studies which involved sensitivity and specificity measures of diagnostic accuracy.


Fourteen total studies were included in the given review. Qualitative analysis of the articles showed that nine studies demonstrated an overlap between metabolic and perfused brain maps as derived by FDG-PET and ASL-MRI respectively, while the remaining five studies registered significant differences across both modalities, with superiority to FDG-PET. As for the meta-analysis implemented, summary ROC-curve analysis revealed that FDG-PET performed better than ASL-MRI, with pooled sensitivity being significantly higher for FDG-PET.


Comparing the diagnostic value of FDG-PET and ASL-MRI, the results of this systematic review and meta-analysis indicate that FDG-PET still has an advantage over ASL-MRI. Such implication could be related to the technical differences relating to both modalities, with ASL-MRI having lower temporal resolution. It’s worth mentioning that specificity was rather quite similar among both modalities and some studies found an overridden metabolic and perfused images. These findings call for future research to focus their scope of investigation while exploring the diagnostic value of ASL-MRI.

Peer Review reports


Dementia is derived from the Latin word “de mens” which describes the deteriorating aspect of mental capabilities [1]. According to the World Health Organization (WHO), dementia is defined as a health problem resulting from a chronic disease inflicting the brain [2]. The result of this progressive decline is the inability of a person to perform some major higher cortical functions including memory, learning, and thinking [3]. Neuropsychiatric symptoms are commonly found in demented patients, and they involve depression, agitation, and apathy [4]. Worldwide, it is estimated that 44 million people are suffering from dementia, with that number doubling every 20 years till the year 2050 [5]. Each year there are around 7.7 million new cases of dementia registered with most of these cases centered in low and middle-income countries [6].

Alzheimer’s disease (AD) is the most common neurodegenerative disease affected by and it constitutes 75% of all dementia cases [7]. Alzheimer’s disease is characterized by memory loss and language-related problems [8]. Vascular dementia (VD) is the second cause contributing to dementia cases [2]. It originates from an arterial disease compromising the blood supply to the brain leading to neuronal damage [9]. Other causes include dementia with Lewy bodies (DLB), explaining 10% of dementia cases [10].

In an attempt to diagnose patients with dementia, a number of clinical and cognitive tests are prone to take place to confirm the designated disease. The earlier the diagnosis is made, the better the prognosis [11]. Neuroimaging is an important subset of these diagnostic tests. They offer biomarkers, which are considered helpful predictors in following up the trajectory of the disease [12]. Neuroimaging techniques employed include structural imaging, like computed tomography (CT), and functional imaging. The latter involves mainly positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) [13].

Fluorodeoxyglucose-PET (FDG-PET) scan is employed in the early assessment and differential diagnosis of dementia [14]. Neuroimaging biomarkers detected on FDG-PET include hypometabolism patterns in the posterior cingulate gyrus, parietal lobe, frontal lobe, and anterior and posterior temporal lobes, with sensorimotor cortex involvement [15]. Despite FDG-PET being highly beneficial in the diagnosis of dementia, still several shortcomings are facing its easy maneuver which involve high exposure to radiation, inaccessibility in many developing countries, and its high cost [16]. Thus, other substitutes were investigated to replace the usage of FDG-PET in detecting dementia including arterial-spin-labelling magnetic resonance imaging (ASL-MRI). This technique in MRI uses a labelled magnetic arterial tracer to measure regional cerebral blood flow [17]; as glucose metabolism and cerebral blood flow are biologically coupled [18].

Several studies in the literature have explored and compared the ability of FDG-PET and ASL-MRI to detect dementia. Ceccarini et al. compared the diagnostic ability of ASL-MRI and FDG-PET in differentiating dementia patients and controls [19]. Equivalent specificity was registered (0.7) with higher sensitivity for FDG-PET (0.93). In a case-control study simultaneously comparing ASL-MRI and FDG-PET diagnostic values in a sample of Alzheimer’s disease and frontotemporal dementia patients, Fällmar et al. results have shown higher specificity for ASL-MRI (0.84), but lower sensitivity in comparison to FDG-PET (0.53 versus 0.96) [20].

Henceforth, the former findings derived from literature suggest that FDG-PET and ASL-MRI are comparable, and that both can offer important information about the diagnosis of demented patients. With that kept in mind, our main purpose in this systematic review and meta-analysis is to summarize the results relating to the diagnostic values of ASL-MRI and FDG-PET in correctly distinguishing dementia cases. Our review will combine a qualitative assessment of all studies, and a meta-analysis summarizing sensitivity and specificity measures.

Materials and methods

The following systematic review follows the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses- Diagnostic Test Accuracy (PRISMA-DTA) [21] for reporting systematic reviews of diagnostic test accuracy studies.

Eligibility criteria

Studies were considered eligible for recruitment if they involved dementia patients of any disease, where these patients were examined using both ASL-MRI and FDG-PET during the same interval of time. There was no restriction on time nor gender. Studies were excluded if recruited patients in the retrieved studies were younger than 18 years of age, had an accompanying history of diseases like epilepsy, have received corticosteroid treatment, or underwent radiotherapy or other treatments before imaging studies were attained.

Information sources

An electronic database search was employed to extract the eligible articles from literature. Electronic databases searched included PubMed, CORE, Cochrane, and additional academic journals being biomedical central journal, Neurology journal, Journal of Neuroimaging, Radiology Journal, Annals of Neurology, and Journal of MRI.

Search strategy

Literature was searched through online electronic databases, from March till May 2022, using MeSH terms that involved “dementia”, “FDG-PET”, “PET-scan”, “ASL-MRI”, and “arterial spin labeling”. The former MeSH terms were combined by Boolean operators “OR” and “AND”. The adjusted search overall was in the following form: (“dementia” AND (“FDG-PET” OR “PET-scan”) AND (“Arterial spin labeling” OR “ASL”)).

Study selection

Two reviewers (HH and SH) have separately and independently navigated the literature and assessed the articles for inclusion. If there was any disagreement among the reviewers, a discussion was set to resolve it.

Data extraction and quality assessment

Information extracted from all included articles is as follows: study’s citation, study design, target condition, sample size of healthy and diseased patients, index tests used, assessment method for analyzing the data received from the employed imaging modalities (visual versus quantitative), the diagnostic accuracy measures reported, and the main findings of the study.

In addition to the previous process of data extraction, studies that provided diagnostic accuracy measures in the form of sensitivity and specificity had an additional separate process of data extraction. Data extracted or derived from these latter articles involved the study’s citation, target condition, assessment method of data acquired from index tests, sensitivity, specificity, positive predictive value, and negative predictive value.

Studies’ risk of bias was evaluated by the Quality Assessment of Diagnostic Accuracy Studies tool, version 2 (QUADAS-2) [22].

Data interpretation and statistical analysis

Eligible articles were qualitatively assessed and interpreted. Imaging-based findings were separately and qualitatively summarized for all articles. On the other side, studies that reported sensitivity and specificity measures were part of the meta-analysis executed.

Qualitative analysis of the articles consisted mainly of providing a narrative summary of the findings related to metabolized versus perfused brain patterns, while categorizing them based on the nature of the dementia-related disease.

As for the meta-analysis, sensitivity and specificity diagnostic measures were extracted from selected studies and converted into true positive (TP), true negative (TN), false positive (FP), and false negative (FN) values to be able to undertake the necessary statistical analyses. Pooled sensitivity and specificity values were estimated and compared while being clearly demonstrated using Forest plots per imaging modality.

A summary receiver-operator characteristic curve (SROC-curve) was constructed based on a bivariate model provided by Reitsma [23]. The applied approach considers the correlation between sensitivity and specificity and within-study variations. The necessary parameters required for fitting the model into the SROC curve were extracted using MetaDTA [24] online software. Area under the curve (AUC) and heterogeneity index I2 were calculated with the statistical analysis software RStudio using mada package.

All statistical analyses, summary curves and forest plots were performed using MetaDTA [24], RStudio version 4.2.1, and review manager (REVMAN) version 5.4.1.


Literature search findings

The overall literature search yielded a total of 373 articles, of which 112 articles were screened for eligibility after reading through their title and abstract only. Of these 112 articles, only 16 articles were sought for retrieval. Fourteen articles were overall included (Fig. 1).

Fig. 1
figure 1

PRISMA flow diagram used for studies’ selection

Study characteristics

All articles included are case-control studies except for two [2526]. All of these studies have incorporated FDG-PET and ASL-MRI to compare their diagnostic value in identifying dementia. Data retrieved from both modalities were blindly compared and interpreted using visual assessment (performed by neuroradiologists and imaging specialists), quantitative assessment which involved statistical models for comparison, or both methods.

For comparison purposes between both imaging techniques, varying diagnostic accuracy measures were thereby documented including receiver-operator characteristic curve analyses, sensitivity, and specificity. Nonetheless, imaging-derived brain maps were compared using several analysis techniques like voxel-wise, region-of-interest, and volume-of-interest analyses (Table 1).

Table 1 Study characteristics of included articles

To execute the meta-analysis, studies which have reported sensitivity and specificity measures of diagnostic accuracy were combined and summarized. Six out of the fourteen total articles included for the systematic review have clearly reported sensitivity and specificity values. However, there were more than one report of sensitivity/specificity for some studies based on either the dementia-related disease investigated (some studies have reported two or more diseases), or the method of assessing data (visual versus quantitative).

As it is demonstrated in Table 2, each study of the six articles included in the meta-analysis has documented one or more sets of sensitivity and specificity measures of diagnosis. Positive and negative predictive values were derived and calculated from the data available in the given articles.

Table 2 Meta-analysis study characteristics

Quality assessment

Risk of bias was significantly high in 2 out of the 14 articles in the patient selection domain, whereas 8 articles had unclear risk of bias, and 4 articles showed low risk. In the index test domain, only one study showed unclear risk, but the rest of the articles had low risk of bias. All articles had low risk in the remaining domains along with the applicability concerns (Fig. 2). Figure 3 further illustrates the risk of bias and applicability concerns summary per article.

Fig. 2
figure 2

Risk of bias and applicability concerns graph: review authors’ judgements about each domain presented as percentages across included studies

Fig. 3
figure 3

Risk of bias and applicability concerns summary: review authors’ judgements about each domain for each included study

Qualitative analysis


Several studies found similar perfusion and metabolism brain maps when assessing patients with Alzheimer’s disease. Hypometabolism and hypoperfusion patterns within these studies coincided in regions including the bilateral angular gyri and posterior cingulate [28], precuneus, parietal, temporal, and occipital cortices [3133], and inferior parietal lobule [3536]. On the contrary to these findings, the other set of the studies exhibited significant differences between both imaging techniques. Fällmar et al. compared the diagnostic value of both modalities in evaluating AD. Lower sensitivity was registered for ASL-MRI (0.53) versus that of FDG-PET (0.96). It indicated that hypometabolic areas indicating abnormality were sparser than those hypoperfused ones [20]. Likewise, Tosun et al. and Verclytte et al. deduced that whole-brain metabolism and perfusion patterns were significantly different [2534].


Other studies investigated frontotemporal dementia by which some of them illustrated similar patterns of hypoperfusion and hypometabolism in the medial and lateral fronto-orbital, inferior, middle, superior frontal, precuneus, insular, and medial prefrontal cortices [3536]. On the other side, Anazodo et al. found that hypometabolism areas exceeded that of hypoperfused ones [27]. Comparably, Fällmar et al. showed that ASL-MRI has lower sensitivity, indicating that areas of hypometabolism are far more spread than those of produced by ASL-MRI [20].


Dolui et al. studied the diagnostic value of ASL-MRI and FDG-PET in evaluating patients with mild cognitive impairment on the AD continuum. Brain maps showed abnormalities in common areas including the medial temporoparietal regions [30]. In contrary to what preceded, results from both Riederer et al. and Tosun et al. suggested no overlapping metabolism and perfusion areas among a sample of patients with MCI [3334].


Corouge et al. examined semantic dementia. Hypoperfusion and hypometabolism were observed in areas including basifrontal, anterior temporal lobe, left posterior part of the temporal lobe, and left parietal lobe [29]. As for dementia with Lewy bodies, Nedelska et al. results indicated a similarity in the hypometabolism and hypoperfusion brain patterns of the cortex in areas including precuneus, cuneus and posterior parieto-occipital cortices [32].

Weyts et al. probed several dementia-related diseases. Intermodality agreement was similar in some brain regions including the precuneus, anterior cingulate, anterior temporal lobe, and primary sensorimotor area [26]. Conversely to Weyts, ceccarini et al. results displayed, after examination of multiple dementia-related diseases, that FDG-PET manifested more volume and intensity abnormalities than ASL-MRI [19].


A meta-analysis was employed to summarize the sensitivity and specificity measures of diagnostic accuracy while comparing both imaging techniques. Table 2 summarizes all extracted and derived data from the six articles included in the meta-analysis.

Forest plots

Forest plots were created to summarize the diagnostic accuracy measures of FDG-PET and ASL-MRI. As it is clarified in Fig. 4, twelve total reports of sensitivity/specificity measures were employed from the six articles included. Articles which had more than one set of sensitivity/specificity measures were registered as a copy to the original study reference, with a letter (a) suggesting a first copy, and a letter (b) suggesting a second copy. It can be noticed from the plot that each report is defined by the dementia and analysis type.

Fig. 4
figure 4

Forest plot of tests: 1 FDG-PET, 2 ASL-MRI.

Pooled sensitivity and specificity

From the twelve reported sets of sensitivity and specificity measures of diagnostic accuracy, the mean value has been calculated. Concerning sensitivity, the estimated pooled value for FDG-PET is 0.858, much greater than that of ASL-MRI (0.71) (Table 3). On the hand, estimated pooled specificity of FDG-PET and ASL-MRI are quite similar, with values being 0.863 and 0.834 respectively (Table 3).

Table 3 Pooled sensitivity and specificity measures of FDG-PET and ASL-MRI (lower and upper confidence intervals)

Summary-ROC curve analysis

A ROC-curve was created to further illustrate the results of the meta-analysis conducted as seen in Fig. 5. The curve was constructed based on a bivariate model using parameters calculated using the MetaDTA software [24]. It can be noted from figure five that FDG-PET demonstrated a higher overall diagnostic performance than ASL-MRI. Summary point of FDG-PET is higher than that of ASL-MRI. In addition, area under curve (AUC) was estimated using RStudio software per imaging modality. The SROC curve describing FDG-PET has an AUC of 86.7%, greater than that of ASL-MRI being 84.2%.

Fig. 5
figure 5

Summary ROC Plot of tests: BLACK: FDG-PET, RED: ASL-MRI.

Heterogeneity considerations

To investigate the heterogeneity of the studies included in the meta-analysis and understand whether there are factors affecting the variability of both diagnostic measures, sensitivity and specificity, I2 index based on the approach described by Zhou and Dendukuri [37] was extracted from mada package on RStudio. The later approach is used for bivariate meta-analysis, and it therefore considers the correlation between sensitivity and specificity measures. It offers a better explanation for the variation within diagnostic test accuracy studies than the model derived by Higgins and Thompson [38].

The heterogeneity I2 index, as described by Zhou and Dendukuri [37], equals to 0% when taking into consideration FDG-PET studies, and it is 6% when considering ASL-MRI studies separately. Both percentages indicate that the heterogeneity of studies included is exceptionally low for both modalities, implying that there isn’t a significant variation between and within studies.


Dementia comes in many forms, and it is portrayed through various diseases including Alzheimer’s disease, fronto-temporal dementia, and dementia with Lewy bodies. FDG-PET is a commonly used imaging modality in the diagnosis of the varying dementia-related diseases. However, FDG-PET is known for being expensive and selectively available. Thus, seeking an alternative to FDG-PET is a common target for researchers and clinicians. ASL-MRI is a technique navigated by MRI. It is far cheaper than FDG-PET and is rather widely secured for people. Thereby, the following systematic review and meta-analysis was performed to compare literature findings related to the diagnostic ability of FDG-PET and ASL-MRI, and to conclude whether ASL-MRI is an eligible efficient alternative for FDG-PET.

A search of the available electronic literature review yielded a total of fourteen articles to be reviewed and assessed. All articles were qualitatively evaluated and systematically reviewed. Nonetheless, a meta-analysis was performed combining six out of the fourteen articles, for they reported sensitivity and specificity measures of diagnostic accuracy. Our results have shown, from a qualitative perspective, that studies are on opposite sides of the spectrum. Some studies have identified metabolism and perfusion brain maps to overlap in various brain regions depending on the disease investigated. However, other studies couldn’t find overridden brain regions among metabolism and perfusion brain maps, emphasizing that FDG-PET performed better at the diagnostic level. From a quantitative perspective, our meta-analysis revealed, as per the SROC-curve and AUC measures, that FDG-PET with an AUC of 86.7%, displays a better diagnostic performance than ASL-MRI with an AUC of 84.2%. The pooled sensitivity of FDG-PET is 0.858, significantly higher than that of ASL-MRI (0.71). Specificity was rather similar among both techniques (0.863 (FDG-PET) versus 0.834 (ASL-MRI)).

Generally speaking, our results indicate that FDG-PET still holds an advantage over ASL-MRI in diagnosing dementia. This could be explained by the fact that FDG-PET measures glucose metabolism which is highly sensitive to neuronal and synaptic activity changes reflecting back directly any degeneration or alteration [39]. On the other side, ASL-MRI measures cerebral blood flow which is coupled to neuronal activity; activation in certain brain regions would normally increases the blood flow to these regions [40]. However, ASL-MRI is characterized with low temporal resolution. Thus, changes with high pace are often not detected or lagged behind [41]. Nonetheless, studies included for the following review differed on various aspects including the nature of the disease investigated (early-onset versus late-onset), the sample size provided per each case, and the imaging techniques involved. Such discrepancies could have introduced bias within the deduced results.

Our findings somewhat coincide with a previous review comparing the diagnostic performance of ASL-MRI to FDG-PET and other neuroimaging modalities in the diagnosis of various neurological diseases including dementia. Quantitative summary of results derived from literature have indicated that there’s a regional overlap between hypometabolism and hypoperfusion data when considering patients suffering from dementia like AD and FTD patients [42]. The latter conclusion calls for investigating the possibility of securing an alternative to FDG-PET.

The given systematic review and meta-analysis is the first review to summarize the findings comparing the diagnostic accuracy of FDG-PET and ASL-MRI in solely differentiating demented patients from healthy ones. In addition, qualitative and quantitative analyses were both employed. Using qualitative analysis, a summary of the results extracted from studies was outlaid. Quantitatively, a meta-analysis of sensitivity and specificity measures of diagnostic accuracy was undertaken to compare the diagnostic value of both modalities.

Despite the significance of this systematic review, it still holds several shortcomings to be highlighted. The number of articles included is low, and the type of our review is a diagnostic test accuracy (DTA) review. This type of reviews is known to be characterized with several limitations. The majority of studies included for the review followed a case-control design, and such design might exaggerate the diagnostic value of tests [43]. Moreover, this type of review doesn’t always provide a clear explanation of the selection criteria and sampling of participants [44].

Heterogeneity pertaining results variation is another limitation in a diagnostic accuracy test review. As different studies have used different cut-off values in determining the sensitivity and specificity measures of diagnostic accuracy, results recorded would substantially vary from one study to another. However, our meta-analysis revealed a low heterogeneity index, which could be attributed to having several sets of sensitivity and specificity in the same study, decreasing the variations across studies, which is counted as a great advantage to the systematic review.

With the overall results suggesting that FDG-PET performs better at the diagnostic level for distinguishing dementia patients, still an undeniable part of the results shows that ASL-MRI somewhat performs in a similar way to FDG-PET. Qualitative findings did mention that metabolism and perfusion brain maps override each other in specific regions. In addition, while comparing the diagnostic accuracy between FDG-PET and ASL-MRI, specificity was somehow close in value which indicates a similar performance at that level. This definitely hints on the possibility that ASL-MRI could replace FDG-PET for the many advantages it possesses, if researchers can prove that this technique can guarantee an undistinguishable sensitivity from that of FDG-PET. Thus, it is recommended for future research to explore the effect of some variations, like the disease investigated or the method of assessing the imaging data, on the studies’ heterogeneity in order to decrease the impact of the heterogeneity-evoking factors, and to settle for more accurate comparisons between the two imaging modalities.


In spite of the former limitations, our systematic review has successfully met the main research objective. With the systematic review and meta-analysis undertaken, a well-established comparison between FDG-PET and ASL-MRI in diagnosing dementia patients was maintained. While identifying any overlap in metabolism and perfusion brain regions, qualitative findings showed either a similar diagnostic ability of ASL-MRI to FDG-PET, or a diagnostic advantage of FDG-PET over ASL-MRI. On the other hand, the meta-analysis implemented, which summarized sensitivity and specificity measures of diagnostic accuracy, revealed a higher performance associated with FDG-PET. Henceforth, our results although favor FDG-PET in the diagnosis of dementia, still some evidence shedding light on an equivalent performance by ASL-MRI can certainly be further investigated.

Availability of data and matarials

All data generated or analyzed during this study are included in this published article.



World health organization


Alzheimer’s disease


Vascular dementia


Dementia with Lewy bodies


Computed tomography


Positron emission tomography


Functional magnetic resonance imaging


Arterial spin labeling - magnetic resonance imaging


Fluorodeoxyglucose-positron emission tomography


Preferred Reporting Items for Systematic Reviews and Meta-Analyses- Diagnostic Test Accuracy


Quality Assessment of Diagnostic Accuracy Studies tool, version 2


True positive


True negative


False negative


Summary receiver-operator characteristic curve


Review manager


Frontotemporal dementia


Semantic dementia


Mild cognitive impairment


Behavioral variant of frontotemporal dementia


Early-onset Alzheimer’s disease


Area under curve


  1. Gustafson L. What is Dementia? Acta Neurol Scand. 1996;94:22–4.

    Article  Google Scholar 

  2. Dening T, Sandilyan MB. Dementia: definitions and types. Nurs Standard (2014+). 2015;29(37):37.

    Article  Google Scholar 

  3. World Health Organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization; 1992.

  4. van der Flier WM, Scheltens P. Epidemiology, and risk factors of Dementia. J Neurol Neurosurg Psychiatry. 2005;76(suppl 5):v2-7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Alzheimer’s Disease International. World Alzheimer Report 2014: Dementia and Risk Reduction. (2014).

  6. Alzheimer’s Disease International. Dementia Statistics. (2013).

  7. Qiu C, Kivipelto M, Von Strauss E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111–28.

  8. Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, Breitner JC, Steffens DC, Tschanz JT. Point and 5‐year period prevalence of neuropsychiatric symptoms in Dementia: the Cache County study. Int J Geriatric Psychiatry: J Psychiatry late life Allied Sci. 2008;23(2):170–7.

    Article  Google Scholar 

  9. Jackson K, Barisone GA, Diaz E, Jin LW, DeCarli C, Despa F. Amylin deposition in the brain: a second amyloid in Alzheimer Disease? Ann Neurol. 2013;74(4):517–26.

    Article  CAS  PubMed  Google Scholar 

  10. Matsui Y, Tanizaki Y, Arima H, Yonemoto K, Doi Y, Ninomiya T, Sasaki K, Iida M, Iwaki T, Kanba S, Kiyohara Y. Incidence and survival of Dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry. 2009;80(4):366–70.

    Article  CAS  PubMed  Google Scholar 

  11. Diagnostic criteria for dementia. (2019).

  12. Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K. Preclinical Alzheimer’s Disease: definition, natural history, and diagnostic criteria. Alzheimer’s Dement. 2016;12(3):292–323.

    Article  Google Scholar 

  13. Dipanjan B, Abilash M, Rub HM, Haider MB. Neuroimaging in Dementia: a brief review. Cureus. 2020;12(6):e8682.

    Google Scholar 

  14. Sarikaya I, Sarikaya A, Elgazzar AH. Current status of 18F-FDG PET brain imaging in patients with Dementia. J Nucl Med Technol. 2018;46(4):362–7.

    Article  PubMed  Google Scholar 

  15. Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected Dementia: patterns of altered FDG metabolism. Radiographics: A Review Publication of the Radiological Society of North America Inc. 2014;34(3):684–701.

    Article  PubMed  Google Scholar 

  16. Sone D, Maikusa N, Sato N, Kimura Y, Ota M, Matsuda H. Similar and differing distributions between 18F-FDG-PET and arterial spin labeling imaging in temporal lobe Epilepsy. Front Neurol. 2019;10: 318.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med. 1992;23(1):37–45.

    Article  CAS  PubMed  Google Scholar 

  18. Raichle ME. Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci. 1998;95(3):765–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ceccarini J, Bourgeois S, Van Weehaeghe D, Goffin K, Vandenberghe R, Vandenbulcke M, Sunaert S, Van Laere K. Direct prospective comparison of 18F-FDG PET and arterial spin labelling MR using simultaneous PET/MR in patients referred for diagnosis of Dementia. Eur J Nucl Med Mol Imaging. 2020;47(9):2142–54.

    Article  CAS  PubMed  Google Scholar 

  20. Fällmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, Egger K, Kellner E, Croon PM, Verfaillie SC, van Berckel BN. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative Dementia compared to FDG-PET. Eur Radiol. 2017;27(10):4237–46.

    Article  PubMed  PubMed Central  Google Scholar 

  21. McInnes MD, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388–96.

    Article  PubMed  Google Scholar 

  22. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. QUADAS-2 Group*. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.

    Article  PubMed  Google Scholar 

  23. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982–90.

    Article  PubMed  Google Scholar 

  24. Freeman SC, Kerby CR, Patel A, Cooper NJ, Quinn T, Sutton AJ. Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA. BMC Med Res Methodol. 2019;19(1):1–1.

    Article  Google Scholar 

  25. Verclytte S, Lopes R, Lenfant P, Rollin A, Semah F, Leclerc X, Pasquier F, Delmaire C. Cerebral hypoperfusion and hypometabolism detected by arterial spin labeling MRI and FDG-PET in early‐onset Alzheimer’s Disease. J Neuroimaging. 2016;26(2):207–12.

    Article  PubMed  Google Scholar 

  26. Weyts K, Vernooij M, Steketee R, Valkema R, Smits M. Qualitative agreement and diagnostic performance of arterial spin labelling MRI and FDG PET-CT in suspected early-stage Dementia: comparison of arterial spin labelling MRI and FDG PET-CT in suspected Dementia. Clin Imaging. 2017;45:1–7.

    Article  PubMed  Google Scholar 

  27. Anazodo UC, Finger E, Kwan BY, Pavlosky W, Warrington JC, Günther M, Prato FS, Thiessen JD, Lawrence KS. Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal Dementia by arterial spin labelling MRI and FDG-PET. NeuroImage. Clinical. 2018;17:405–14.

    Google Scholar 

  28. Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre J. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer Disease. Neurology. 2011;77(22):1977–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Corouge I, Esquevin A, Le Jeune F, Ferré JC, Bannier E, Merck C, Belliard S, Barillot C, Gauvrit JY. Arterial Spin Labeling at 3T in semantic dementia: perfusion abnormalities detection and comparison with FDG-PET. InMICCAI 2012 Workshop on Novel Biomarkers for Alzheimer’s Disease and Related Disorders; 2012. p. 32–40. inserm-00730431, version 1.

  30. Dolui S, Li Z, Nasrallah IM, Detre JA, Wolk DA. Arterial spin labeling versus 18F-FDG-PET to identify mild cognitive impairment. NeuroImage: Clin. 2020;25: 102146.

    Article  PubMed  Google Scholar 

  31. Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer’s Disease. Alzheimer’s Dement. 2012;8(1):51–9.

    Article  Google Scholar 

  32. Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF, Arani A, Vemuri P, Graff-Radford J, Ferman TJ, Jones DT, Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF, Arani A, Vemuri P, Graff-Radford J, Ferman TJ, Jones DT, Savica R, Knopman DS, Petersen RC, Jack CR, Kantarci K. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET. NeuroImage: Clinical. 2018;19:939–47.

    Article  PubMed  Google Scholar 

  33. Riederer I, Bohn KP, Preibisch C, Wiedemann E, Zimmer C, Alexopoulos P, Förster S. Alzheimer Disease and mild cognitive impairment: integrated pulsed arterial spin-labeling MRI and 18F-FDG PET. Radiology. 2018;288(1):198–206.

    Article  PubMed  Google Scholar 

  34. Tosun D, Schuff N, Jagust W, Weiner MW. Alzheimer’’s Disease Neuroimaging Initiative. Discriminative power of arterial spin labeling magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography changes for amyloid-β-positive subjects in the Alzheimer’s Disease continuum. Neurodegenerative Dis. 2016;16(1–2):87–94.

    Article  CAS  Google Scholar 

  35. Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, Kramer J, Weiner MM, Rosen HJ. Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Annals of clinical and translational neurology. 2016;3(10):740–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Verfaillie SC, Adriaanse SM, Binnewijzend MA, Benedictus MR, Ossenkoppele R, Wattjes MP, Pijnenburg YA, van der Flier WM, Lammertsma AA, Kuijer J, Boellaard R. Cerebral perfusion and glucose metabolism in Alzheimer’s Disease and frontotemporal Dementia: two sides of the same coin? Eur Radiol. 2015;25(10):3050–9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Zhou Y, Dendukuri N. Statistics for quantifying heterogeneity in univariate and bivariate meta-analyses of binary data: the case of meta‐analyses of diagnostic accuracy. Stat Med. 2014;33(16):2701–17.

    Article  PubMed  Google Scholar 

  38. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

    Article  PubMed  Google Scholar 

  39. Mosconi L. Glucose metabolism in normal aging and Alzheimer’s Disease: methodological and physiological considerations for PET studies. Clin Translational Imaging. 2013;1(4):217–33.

    Article  Google Scholar 

  40. Malpass K. Arterial spin-labeled MRI for diagnosis and monitoring of AD. Nat Reviews Neurol. 2012;8(1):3.

    Article  Google Scholar 

  41. Borogovac A, Asllani I. Arterial spin labeling (ASL) fMRI: advantages, theoretical constrains and experimental challenges in neurosciences. Int J Biomed Imaging. 2012;2012:818456.

    PubMed  PubMed Central  Google Scholar 

  42. Zhang J. How far is arterial spin labeling MRI from a clinical reality? Insights from arterial spin labeling comparative studies in Alzheimer’s Disease and other neurological disorders. J Magn Reson Imaging. 2016;43:1020–45.

    Article  PubMed  Google Scholar 

  43. Suttie M, Foroud T, Wetherill L, Jacobson JL, Molteno CD, Meintjes EM, Hoyme HE, Khaole N, Robinson LK, Riley EP, Jacobson SW. Facial dysmorphism across the fetal alcohol spectrum. Pediatrics. 2013;131(3):e779-788.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Goh PK, Doyle LR, Glass L, Jones KL, Riley EP, Coles CD, Hoyme HE, Kable JA, May PA, Kalberg WO, Elizabeth RS. A decision tree to identify children affected by prenatal alcohol exposure. J Pediatr. 2016;177:121–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


Not applicable.


Not applicable.

Author information

Authors and Affiliations



H.H wrote the manuscript. R.M. assessed and reviewed the manuscript throughout the whole process of writing it down. S.H. and L.A. mainly contributed to the methodology and results sections, with S.H running the statistical tests required including the meta-analysis. All authors revised the manuscript ahead of submission.

Corresponding author

Correspondence to Hiba Haidar.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haidar, H., Majzoub, R.E., Hajeer, S. et al. Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis. BMC Neurol 23, 385 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: